Skip to content

Acceptability and Feasibility of a Stress Prevention Program Based on Meditation and Acceptance and Commitment Therapy for Staff at a Cancer Center

Acceptability and Feasibility of a Stress Prevention Program Based on Meditation and Acceptance and Commitment Therapy for Staff at a Cancer Center

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT06903104
Acronym
MAEva-pro
Enrollment
20
Registered
2025-03-30
Start date
2025-03-13
Completion date
2025-09-13
Last updated
2025-12-26

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Employees at a Hospital

Keywords

MAEva program, Quality of life, Mindfulness, Workplace, Caregivers

Brief summary

The MAEva program seems to meet the challenges of implementing meditation for cancer care workers. As part of our Quality of Life and Working Conditions initiative, the investigator decided to offer it to staff at our Cancer Center. The MAEva program is delivered in a closed format: participants commit to following, as far as possible, the three sessions of the program - one session per week for 3 weeks. During the sessions, it will be proposed to train meditative practices and three different themes will be addressed (one theme per session): Meditation, Acceptance and Commitment to values. Before and after the program, participants will complete a quality of life evaluation, a perceived stress scale, and a questionnaire to assess psychological flexibility. At the end of the program, each participant will be asked to complete a satisfaction questionnaire and a semi-directive interview, by videoconference, or by telephone in the event of digital impossibility with voice recording, to enable a qualitative analysis.

Interventions

OTHERMindfulness closed program

MAEva program will be proposed with meditative practices and three different themes will be addressed (one theme per session): Meditation, Acceptance and Commitment to values.

The assessment will be carried out at inclusion and after completion of the program.

DIAGNOSTIC_TESTPerceived Stress Scale

The assessment will be carried out at inclusion and after completion of the program.

DIAGNOSTIC_TESTMultidimensional Psychological Flexibility Inventory

The assessment will be carried out at inclusion and after completion of the program.

OTHERsatisfaction questionnaire and semi-structured interview

The assessments will be carried out after completion of the program.

Sponsors

Institut de Cancérologie de Lorraine
Lead SponsorOTHER

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
PREVENTION
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
Yes

Inclusion criteria

* Participant of legal age * Willingness to participate in the program - voluntary registration * Commitment to attend all 3 program sessions * Schedule compatible with participation in the 3 program sessions * Participant has understood, signed and dated the consent form * Participant affiliated to the social security system

Exclusion criteria

* No desire to participate in the program - non-registration * Previous participation in MAEva program * No commitment to participate in the 3 program sessions * Agenda incompatible with the 3 program sessions

Design outcomes

Primary

MeasureTime frameDescription
Evaluate the feasibility and acceptability of the MAEva program among employees at a hospital (CLCC: Centre de Lutte Contre le Cancer or Cancer Center).5 weeksParticipation rate of employees at a hospital in the MAEva program and number of sessions attended (number of participants who completed the entire program)

Secondary

MeasureTime frameDescription
Evaluate the initial effectiveness of the MAEva program on the well-being of employees at a hospital.5 weeksQuality of working life assessment (subjective score between 1 and 10 on the Quality of Working Life Scale)

Countries

France

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026